Asia-Pacific Infectious Disease Therapeutics Market by Mode of Treatment- (Drugs, Vaccines), by target organism – (Antibacterial, Antifungal, Antiviral, Antiparasitic, others) by infection type – (Bacterial, Viral, fungal, Parasitic, others), by distribution channels (Hospitals, Clinics and others) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia-Pacific Infectious Disease Therapeutics Market by Mode of Treatment- (Drugs, Vaccines), by target organism – (Antibacterial, Antifungal, Antiviral, Antiparasitic, others) by infection type – (Bacterial, Viral, fungal, Parasitic, others), by distribution channels (Hospitals, Clinics and others) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1323 | Pages: 132 | May 2017 | Region: Asia Pacific


The Asia-Pacific Infectious Disease Therapeutics Market was worth $ 14.43 Billion in 2016 and estimated to reach $ 22.48 Billion by the end of 2021 with a growing potential of 9.27 %. Asia-Pacific is expected to account the second largest share in the market due to increasing pool of patients, and government funding.

Various microorganisms like bacteria, fungi, viruses and parasites and others causes infectious diseases such as HIV, malaria, tuberculosis, influenza. Various infectious diseases are mostly caused by poor sanitation and inadequate personal hygiene. These diseases are transmitted either through direct or indirect contact. Anti-infective drugs are used to inhibit or destroy the growth of disease causing agents. Antibacterial, antifungal, antiparasitic, antiviral drugs are some of the anti- infective drugs used for the treatment of these diseases.

Asia-Pacific market is mainly driven by growing incidence of infectious diseases, rising health care expenditure and growing geriatric population, growing healthcare awareness, increasing government funding’s in developing countries. Generic erosion, Patent expiration of infectious disease drugs are the factors that are hampering the growth of the market.

The Asia-Pacific Infectious disease therapeutics market is categorized based on Mode of treatment into Drugs and Vaccines. The drugs are further segmented into oral administration, topical, injections and others. Based on target organism the market is categorized into antibacterial, antifungal, antiviral, antiparasitic and others. Based on infection type the market is categorized into Bacterial, viral, fungal, parasite and others. Based on distribution channels the market is categorized into hospitals, clinics and others. Based on Geography, the Asia-Pacific Infectious disease therapeutics market is analyzed under various regions namely China, India, Japan and Australia.

some of the major companies operating in Asia-Pacific Infectious disease Therapeutics Market F. Hoffmann-La Roche, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Merck & Co, Pfizer, Achillion Pharmaceuticals, Novartis, AbbVie, , AstraZeneca, Auritec Pharmaceuticals, Bayer, Astellas Pharma, Chimerix Pharmaceuticals, Cubist, Eli Lilly, Isis Pharmaceuticals, Mitsubishi Tanabe Pharma, pSivida, Bristol-Myers Squibb, Sanofi.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Mode of Treatment                

                                5.1.1 Introduction           

                                5.1.2 Drugs        

                                                5.1.2.1 Oral Administration

                                                5.1.2.2 Topical

                                                5.1.2.3 Injections

                                                5.1.2.4 Others

                                5.1.3 Vaccines  

                                5.1.4 Y-o-Y Growth Analysis, By Mode of treatment         

                                5.1.5 Market Attractiveness Analysis, By Mode of treatment        

                                5.1.6 Market Share Analysis, By Mode of treatment         

                5.2 Target Organism                      

                                5.2.1 Introduction           

                                5.2.2 Antibacterial          

                                5.2.3 Antifungal

                                5.2.4 Antiviral   

                                5.2.5 Antiparasite           

                                5.2.6 others       

                                5.2.7 Y-o-Y Growth Analysis, By Target Organism               

                                5.2.8 Market Attractiveness Analysis, By Target Organism             

                                5.2.9 Market Share Analysis, By Target Organism              

                5.3 Infection type                           

                                5.3.1 Introduction           

                                5.3.2 Bacterial   

                                5.3.3 Viral           

                                5.3.4 Fungal       

                                5.3.5 parasitic   

                                5.3.6 others       

                                5.3.7 Y-o-Y Growth Analysis, By Infection type    

                                5.3.8 Market Attractiveness Analysis, By Infection type  

                                5.3.9 Market Share Analysis, By Infection Type   

                5.4 Distribution Channels                            

                                5.4.1 Hospitals  

                                5.4.2 Clinics        

                                5.4.3 Others      

                                5.4.4 Y-o-Y Growth Analysis, By Distribution Channels     

                                5.4.5 Market Attractiveness Analysis, By Distribution Channels   

                                5.4.6 Market Share Analysis, By Distribution Channels    

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Mode of Treatment

                                                6.1.3.3 By Target organism

                                                6.1.3.4 By Infection Type

                                                6.1.3.5 By Distribution Channels

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Mode of Treatment

                                                6.1.4.3 By Target organism

                                                6.1.4.4 By Infection Type

                                                6.1.4.5 By Distribution Channels

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Mode of Treatment

                                                6.1.5.3 By Target organism

                                                6.1.5.4 By Infection Type

                                                6.1.5.5 By Distribution Channels

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 F. Hoffmann-La Roche                           

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Gilead Sciences                         

                8.3 GlaxoSmithKline                      

                8.4 Johnson & Johnson                 

                8.5 Merck & Co                

                8.6 Pfizer                            

                8.7 Achillion Pharmaceuticals                    

                8.8 Novartis                       

                8.9 Abbvie                         

                8.10 Astellas Pharma                     

                8.11 AstraZeneca                            

                8.12 Auritec Pharmaceuticals                     

                8.13 Bayer                          

                8.14 Bristol-Myers Squibb                           

                8.15 Chimerix Pharmaceuticals                 

                8.16 Cubist                         

                8.17 Eli Lilly                        

                8.18 Isis Pharmaceuticals                             

                8.19 pSivida                       

                8.20 Sanofi                         

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Infectious Disease Therapeutics Market By Mode of treatment, From 2016-2021 ( USD Billion )
  2. Asia-Pacific Drugs Market By Region, From 2016-2021 ( USD Billion )
  3. Asia-Pacific vaccines Market By Region, From 2016-2021 ( USD Billion )
  4. Asia-Pacific Infectious Disease Therapeutics Market By Target Organism, From 2016-2021 ( USD Billion )
  5. Asia-Pacific Antibacterial Market By Region, From 2016-2021 ( USD Billion )
  6. Asia-Pacific Antifungal Market By Region, From 2016-2021 ( USD Billion )
  7. Asia-Pacific Antiviral Market By Region, From 2016-2021 ( USD Billion )
  8. Asia-Pacific Antiparasite Market By Region, From 2016-2021 ( USD Billion )
  9. Asia-Pacific Infectious Disease Therapeutics Market By Infection Type, From 2016-2021 ( USD Billion )
  10. Asia-Pacific Bacterial Market By Region, From 2016-2021 ( USD Billion )
  11. Asia-Pacific Viral Market By Region, From 2016-2021 ( USD Billion )
  12. Asia-Pacific Fungal Market By Region, From 2016-2021 ( USD Billion )
  13. Asia-Pacific Parasitic Market By Region, From 2016-2021 ( USD Billion )
  14. Asia-Pacific Infectious Disease Therapeutics Market By Distribution Channels, From 2016-2021 ( USD Billion )
  15. Asia-Pacific Hospitals Market By Region, From 2016-2021 ( USD Billion )
  16. Asia-Pacific Clinics Market By Region, From 2016-2021 ( USD Billion )
  17. Japan Infectious Disease Therapeutics Market By Mode of treatment, From 2016-2021 ( USD Billion )
  18. Japan Infectious Disease Therapeutics Market By Target Organism, From 2016-2021 ( USD Billion )
  19. Japan Infectious Disease Therapeutics Market By Infection Type, From 2016-2021 ( USD Billion )
  20. Japan Infectious Disease Therapeutics Market By Distribution Channels, From 2016-2021 ( USD Billion )
  21. China Infectious Disease Therapeutics Market By Mode of treatment, From 2016-2021 ( USD Billion )
  22. China Infectious Disease Therapeutics Market By Target Organism, From 2016-2021 ( USD Billion )
  23. China Infectious Disease Therapeutics Market By Infection Type, From 2016-2021 ( USD Billion )
  24. China Infectious Disease Therapeutics Market By Distribution Channels, From 2016-2021 ( USD Billion )
  25. India Infectious Disease Therapeutics Market By Mode of treatment, From 2016-2021 ( USD Billion )
  26. India Infectious Disease Therapeutics Market By Target Organism, From 2016-2021 ( USD Billion )
  27. India Infectious Disease Therapeutics Market By Infection Type, From 2016-2021 ( USD Billion )
  28. India Infectious Disease Therapeutics Market By Distribution Channels, From 2016-2021 ( USD Billion )
  29. Asia-Pacific Infectious disease Therapeutics Market By Drugs, From 2016-2021 ( USD Billion )
  30. Asia-Pacific Oral Administration Market By Region, From 2016-2021 ( USD Billion )
  31. Asia-Pacific Topical Market By Region, From 2016-2021 ( USD Billion )
  32. Asia-Pacific Injections Market By Region, From 2016-2021 ( USD Billion )
  33. Japan Infectious disease Therapeutics Market By Drugs, From 2016-2021 ( USD Billion )
  34. China Infectious disease Therapeutics Market By Drugs, From 2016-2021 ( USD Billion )
  35. India Infectious disease Therapeutics Market By Drugs, From 2016-2021 ( USD Billion )
Middle East And Africa Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combinatio...
Latin America Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, ...
Asia Pacific Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, H...
Europe Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, Hormona...
North America Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, ...
Acne Medication Market By Type ( OTC And Prescription Drugs) , By Route Of Administration ( Oral And Topical) , By Drug Class ( Antibiotics, Anti-inflammatory Drugs, Anti Microbial, Combination Drugs, Hormonal Agent...
Middle East And Africa Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxoru...
Latin America Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Be...
Asia Pacific Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bev...
Europe Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bevacizum...
North America Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Be...
Solid Tumor Market By Disease ( Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer And Others) , By Drugs ( Carboplatin, Cisplatin, Gemcitabine, Palcitaxel, Doxorubicin, Bevacizumab, Erl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.